Pyrimidine metabolism, nucleoside diphosphate kinase
| Source | Evidence on protein | Close homologs | 
|---|---|---|
| Cuervo et al. | no | yes: 0 | 
| Hassani et al. | no | yes: 0 | 
| Forrest at al. (metacyclic) | no | yes: 0 | 
| Forrest at al. (procyclic) | no | yes: 0 | 
| Silverman et al. | no | yes: 0 | 
| Pissara et al. | no | yes: 0 | 
| Source | Evidence on protein | Close homologs | 
|---|---|---|
| Pires et al. | no | yes: 0 | 
| Source | Evidence on protein | Close homologs | 
|---|---|---|
| Silverman et al. | no | yes: 0 | 
| Source | Evidence on protein | Close homologs | 
|---|---|---|
| Jamdhade et al. | no | yes: 0 | 
| Source | Evidence on protein | Close homologs | 
|---|---|---|
| DeepLoc | ||
| SignalP6 | no | yes: 0, no: 11 | 
| NetGPI | no | yes: 0, no: 11 | 
| Term | Name | Level | Count | 
|---|---|---|---|
| GO:0005813 | centrosome | 3 | 1 | 
| GO:0005815 | microtubule organizing center | 2 | 1 | 
| GO:0005929 | cilium | 4 | 1 | 
| GO:0005930 | axoneme | 2 | 1 | 
| GO:0042995 | cell projection | 2 | 1 | 
| GO:0043226 | organelle | 2 | 1 | 
| GO:0043227 | membrane-bounded organelle | 3 | 1 | 
| GO:0110165 | cellular anatomical entity | 1 | 1 | 
| GO:0120025 | plasma membrane bounded cell projection | 3 | 1 | 
Related structures:
AlphaFold database: A4IBS5
| Term | Name | Level | Count | 
|---|---|---|---|
| GO:0006793 | phosphorus metabolic process | 3 | 12 | 
| GO:0006796 | phosphate-containing compound metabolic process | 4 | 12 | 
| GO:0008152 | metabolic process | 1 | 12 | 
| GO:0009987 | cellular process | 1 | 12 | 
| GO:0016310 | phosphorylation | 5 | 12 | 
| GO:0044237 | cellular metabolic process | 2 | 12 | 
| Term | Name | Level | Count | 
|---|---|---|---|
| GO:0003824 | catalytic activity | 1 | 12 | 
| GO:0004550 | nucleoside diphosphate kinase activity | 5 | 8 | 
| GO:0016301 | kinase activity | 4 | 12 | 
| GO:0016740 | transferase activity | 2 | 12 | 
| GO:0016772 | transferase activity, transferring phosphorus-containing groups | 3 | 12 | 
| GO:0016776 | phosphotransferase activity, phosphate group as acceptor | 4 | 8 | 
| GO:0019205 | nucleobase-containing compound kinase activity | 5 | 8 | 
| Leishmania | From | To | Domain/Motif | Score | 
|---|---|---|---|---|
| CLV_C14_Caspase3-7 | 236 | 240 | PF00656 | 0.453 | 
| CLV_NRD_NRD_1 | 83 | 85 | PF00675 | 0.422 | 
| CLV_PCSK_KEX2_1 | 43 | 45 | PF00082 | 0.399 | 
| CLV_PCSK_KEX2_1 | 48 | 50 | PF00082 | 0.342 | 
| CLV_PCSK_KEX2_1 | 85 | 87 | PF00082 | 0.474 | 
| CLV_PCSK_PC1ET2_1 | 43 | 45 | PF00082 | 0.399 | 
| CLV_PCSK_PC1ET2_1 | 48 | 50 | PF00082 | 0.342 | 
| CLV_PCSK_PC1ET2_1 | 85 | 87 | PF00082 | 0.570 | 
| CLV_PCSK_PC7_1 | 44 | 50 | PF00082 | 0.389 | 
| CLV_PCSK_SKI1_1 | 43 | 47 | PF00082 | 0.374 | 
| CLV_PCSK_SKI1_1 | 85 | 89 | PF00082 | 0.535 | 
| DOC_MAPK_gen_1 | 140 | 148 | PF00069 | 0.392 | 
| DOC_PP1_RVXF_1 | 118 | 124 | PF00149 | 0.474 | 
| DOC_PP4_FxxP_1 | 69 | 72 | PF00568 | 0.514 | 
| DOC_USP7_MATH_1 | 106 | 110 | PF00917 | 0.470 | 
| DOC_USP7_MATH_1 | 16 | 20 | PF00917 | 0.511 | 
| DOC_USP7_MATH_1 | 188 | 192 | PF00917 | 0.541 | 
| DOC_USP7_MATH_1 | 207 | 211 | PF00917 | 0.349 | 
| DOC_USP7_MATH_1 | 229 | 233 | PF00917 | 0.528 | 
| DOC_USP7_MATH_1 | 323 | 327 | PF00917 | 0.439 | 
| DOC_USP7_MATH_1 | 51 | 55 | PF00917 | 0.397 | 
| DOC_WW_Pin1_4 | 53 | 58 | PF00397 | 0.513 | 
| LIG_14-3-3_CanoR_1 | 120 | 124 | PF00244 | 0.435 | 
| LIG_Actin_WH2_2 | 107 | 122 | PF00022 | 0.357 | 
| LIG_Actin_WH2_2 | 59 | 76 | PF00022 | 0.363 | 
| LIG_BRCT_BRCA1_1 | 325 | 329 | PF00533 | 0.442 | 
| LIG_FHA_1 | 114 | 120 | PF00498 | 0.448 | 
| LIG_FHA_1 | 190 | 196 | PF00498 | 0.406 | 
| LIG_FHA_1 | 40 | 46 | PF00498 | 0.431 | 
| LIG_FHA_1 | 6 | 12 | PF00498 | 0.502 | 
| LIG_FHA_1 | 63 | 69 | PF00498 | 0.355 | 
| LIG_FHA_2 | 234 | 240 | PF00498 | 0.470 | 
| LIG_FHA_2 | 314 | 320 | PF00498 | 0.442 | 
| LIG_LIR_Apic_2 | 12 | 16 | PF02991 | 0.381 | 
| LIG_LIR_Gen_1 | 122 | 129 | PF02991 | 0.475 | 
| LIG_LIR_Gen_1 | 23 | 32 | PF02991 | 0.411 | 
| LIG_LIR_Gen_1 | 241 | 251 | PF02991 | 0.442 | 
| LIG_LIR_Nem_3 | 122 | 126 | PF02991 | 0.470 | 
| LIG_LIR_Nem_3 | 23 | 29 | PF02991 | 0.394 | 
| LIG_LIR_Nem_3 | 241 | 246 | PF02991 | 0.442 | 
| LIG_LIR_Nem_3 | 253 | 257 | PF02991 | 0.453 | 
| LIG_LIR_Nem_3 | 326 | 332 | PF02991 | 0.439 | 
| LIG_LYPXL_yS_3 | 52 | 55 | PF13949 | 0.393 | 
| LIG_MLH1_MIPbox_1 | 325 | 329 | PF16413 | 0.442 | 
| LIG_MYND_1 | 53 | 57 | PF01753 | 0.508 | 
| LIG_SH2_CRK | 247 | 251 | PF00017 | 0.442 | 
| LIG_SH2_CRK | 254 | 258 | PF00017 | 0.442 | 
| LIG_SH2_STAT5 | 13 | 16 | PF00017 | 0.429 | 
| LIG_SH2_STAT5 | 226 | 229 | PF00017 | 0.495 | 
| LIG_SH2_STAT5 | 28 | 31 | PF00017 | 0.270 | 
| LIG_SH2_STAT5 | 61 | 64 | PF00017 | 0.481 | 
| LIG_SH3_3 | 182 | 188 | PF00018 | 0.500 | 
| LIG_SH3_3 | 199 | 205 | PF00018 | 0.381 | 
| LIG_SH3_3 | 280 | 286 | PF00018 | 0.435 | 
| LIG_SH3_3 | 291 | 297 | PF00018 | 0.427 | 
| LIG_SUMO_SIM_par_1 | 125 | 130 | PF11976 | 0.392 | 
| LIG_SUMO_SIM_par_1 | 144 | 150 | PF11976 | 0.375 | 
| LIG_SUMO_SIM_par_1 | 93 | 99 | PF11976 | 0.410 | 
| LIG_TRAF2_1 | 177 | 180 | PF00917 | 0.534 | 
| MOD_CK1_1 | 173 | 179 | PF00069 | 0.426 | 
| MOD_CK2_1 | 106 | 112 | PF00069 | 0.479 | 
| MOD_CK2_1 | 313 | 319 | PF00069 | 0.442 | 
| MOD_CK2_1 | 53 | 59 | PF00069 | 0.424 | 
| MOD_GlcNHglycan | 103 | 106 | PF01048 | 0.406 | 
| MOD_GlcNHglycan | 149 | 152 | PF01048 | 0.434 | 
| MOD_GlcNHglycan | 165 | 168 | PF01048 | 0.424 | 
| MOD_GlcNHglycan | 175 | 178 | PF01048 | 0.486 | 
| MOD_GlcNHglycan | 209 | 212 | PF01048 | 0.267 | 
| MOD_GlcNHglycan | 227 | 230 | PF01048 | 0.267 | 
| MOD_GlcNHglycan | 262 | 265 | PF01048 | 0.245 | 
| MOD_GlcNHglycan | 90 | 93 | PF01048 | 0.501 | 
| MOD_GSK3_1 | 157 | 164 | PF00069 | 0.427 | 
| MOD_GSK3_1 | 16 | 23 | PF00069 | 0.469 | 
| MOD_GSK3_1 | 167 | 174 | PF00069 | 0.333 | 
| MOD_GSK3_1 | 225 | 232 | PF00069 | 0.510 | 
| MOD_GSK3_1 | 27 | 34 | PF00069 | 0.298 | 
| MOD_NEK2_1 | 119 | 124 | PF00069 | 0.338 | 
| MOD_NEK2_1 | 129 | 134 | PF00069 | 0.350 | 
| MOD_NEK2_1 | 20 | 25 | PF00069 | 0.475 | 
| MOD_NEK2_1 | 225 | 230 | PF00069 | 0.442 | 
| MOD_NEK2_1 | 328 | 333 | PF00069 | 0.443 | 
| MOD_PIKK_1 | 113 | 119 | PF00454 | 0.438 | 
| MOD_PIKK_1 | 167 | 173 | PF00454 | 0.504 | 
| MOD_PK_1 | 157 | 163 | PF00069 | 0.504 | 
| MOD_PKA_1 | 85 | 91 | PF00069 | 0.565 | 
| MOD_PKA_2 | 119 | 125 | PF00069 | 0.367 | 
| MOD_PKA_2 | 5 | 11 | PF00069 | 0.409 | 
| MOD_PKA_2 | 85 | 91 | PF00069 | 0.565 | 
| MOD_Plk_1 | 31 | 37 | PF00069 | 0.365 | 
| MOD_Plk_2-3 | 31 | 37 | PF00069 | 0.364 | 
| MOD_Plk_4 | 106 | 112 | PF00069 | 0.366 | 
| MOD_Plk_4 | 5 | 11 | PF00069 | 0.458 | 
| MOD_ProDKin_1 | 53 | 59 | PF00069 | 0.510 | 
| MOD_SUMO_rev_2 | 174 | 184 | PF00179 | 0.471 | 
| TRG_DiLeu_BaEn_1 | 253 | 258 | PF01217 | 0.442 | 
| TRG_DiLeu_BaEn_4 | 319 | 325 | PF01217 | 0.442 | 
| TRG_ENDOCYTIC_2 | 247 | 250 | PF00928 | 0.442 | 
| TRG_ENDOCYTIC_2 | 254 | 257 | PF00928 | 0.442 | 
| TRG_ENDOCYTIC_2 | 52 | 55 | PF00928 | 0.378 | 
| TRG_ER_diArg_1 | 84 | 87 | PF00400 | 0.523 | 
| TRG_Pf-PMV_PEXEL_1 | 255 | 259 | PF00026 | 0.267 | 
| Protein | Taxonomy | Sequence identity | Coverage | 
|---|---|---|---|
| A0A0N1IJQ8 | Leptomonas seymouri | 28% | 98% | 
| A0A0N1PC23 | Leptomonas seymouri | 73% | 100% | 
| A0A0S4IXH2 | Bodo saltans | 55% | 100% | 
| A0A1X0P5C0 | Trypanosomatidae | 58% | 100% | 
| A0A1X0PAT4 | Trypanosomatidae | 27% | 96% | 
| A0A3Q8IJQ8 | Leishmania donovani | 100% | 100% | 
| A0A3R7M6K1 | Trypanosoma rangeli | 27% | 97% | 
| A0A3R7N390 | Trypanosoma rangeli | 60% | 100% | 
| A0A3S7X855 | Leishmania donovani | 28% | 98% | 
| A4HB17 | Leishmania braziliensis | 29% | 100% | 
| A4HN58 | Leishmania braziliensis | 91% | 100% | 
| A4IA74 | Leishmania infantum | 28% | 100% | 
| C9ZM33 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 29% | 97% | 
| C9ZYU7 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 59% | 100% | 
| E9AFL1 | Leishmania major | 99% | 100% | 
| E9B587 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 28% | 100% | 
| E9B6R5 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 97% | 100% | 
| Q4Q2P6 | Leishmania major | 29% | 100% | 
| Q5E9Y9 | Bos taurus | 34% | 89% | 
| Q9QXL7 | Rattus norvegicus | 36% | 85% | 
| Q9QXL8 | Mus musculus | 34% | 85% | 
| Q9Y5B8 | Homo sapiens | 35% | 90% | 
| V5BXY9 | Trypanosoma cruzi | 59% | 97% | 
| V5DLW4 | Trypanosoma cruzi | 28% | 96% |